Anzeige
Mehr »
Freitag, 27.06.2025 - Börsentäglich über 12.000 News
Blockbuster-Bohrergebnisse: Gold-Antimon-Fund in Nevada trifft geopolitischen Nerv
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2N6P0 | ISIN: US50015M1099 | Ticker-Symbol: K27
Frankfurt
27.06.25 | 08:05
3,138 Euro
+2,42 % +0,074
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
KODIAK SCIENCES INC Chart 1 Jahr
5-Tage-Chart
KODIAK SCIENCES INC 5-Tage-Chart
RealtimeGeldBriefZeit
3,1443,19819:53
3,1363,19819:50

Aktuelle News zur KODIAK SCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
03.06.Kodiak Sciences Inc. - 8-K, Current Report1
14.05.Kodiak Sciences Inc. - 10-Q, Quarterly Report11
KODIAK SCIENCES Aktie jetzt für 0€ handeln
14.05.Kodiak Sciences Inc.: Kodiak Sciences Announces Recent Business Highlights and First Quarter 2025 Financial Results140PALO ALTO, Calif., May 14, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the first...
► Artikel lesen
31.03.H.C. Wainwright holds Kodiak Sciences stock at Neutral, $3 target9
27.03.Kodiak Sciences GAAP EPS of -$0.84 beats by $0.055
27.03.Kodiak Sciences Inc.: Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results434PALO ALTO, Calif., March 27, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the...
► Artikel lesen
27.03.Kodiak Sciences Inc. - S-8, Securities to be offered to employees in employee benefit plans1
27.03.Kodiak Sciences Inc. - 10-K, Annual Report1
27.03.Kodiak Sciences Inc. - 8-K, Current Report1
10.03.Kodiak Sciences Inc.: Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy273Topline clinical data of the confirmatory registrational study GLOW2 expected in 1Q 2026. GLOW2 study design mirrors GLOW1 study, which met primary endpoint and...
► Artikel lesen
13.01.Here's Why Kodiak Sciences Inc. (KOD) Is Skyrocketing14
14.11.24Kodiak Sciences Inc.: Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2024 Financial Results744PALO ALTO, Calif., Nov. 14, 2024 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported business highlights and financial results for the quarter...
► Artikel lesen
14.08.24Kodiak Sciences Inc.: Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2024 Financial Results685PALO ALTO, Calif., Aug. 14, 2024 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported business highlights and financial results for the quarter ended June 30, 2024. "Our three clinical...
► Artikel lesen
13 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1